{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:07Z","timestamp":1786988047340,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejim.2023.05.021","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T07:46:59Z","timestamp":1684568819000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-4240","authenticated-orcid":false,"given":"Alper Tuna","family":"G\u00fcven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-1210","authenticated-orcid":false,"given":"Murat","family":"\u00d6zdede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-5133","authenticated-orcid":false,"given":"Yusuf Ziya","family":"\u015eener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Osman","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5051-9116","authenticated-orcid":false,"given":"Sabri Engin","family":"Alt\u0131ntop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-7111","authenticated-orcid":false,"given":"Berkay","family":"Ye\u015filyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O\u011fuz Abdullah","family":"Uyaro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-4389","authenticated-orcid":false,"given":"Mine Durusu","family":"Tanr\u0131\u00f6ver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4s","key":"10.1016\/j.ejim.2023.05.021_bib0001","article-title":"KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"98","year":"2020","journal-title":"Kidney Int"},{"issue":"3s","key":"10.1016\/j.ejim.2023.05.021_bib0002","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2023.05.021_bib0003","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"Bmj"},{"issue":"36","key":"10.1016\/j.ejim.2023.05.021_bib0004","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2023.05.021_bib0005","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"33","key":"10.1016\/j.ejim.2023.05.021_bib0006","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2023.05.021_bib0007","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.112.194167","article-title":"Initial monotherapy and combination therapy and hypertension control the first year","volume":"59","author":"Egan","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejim.2023.05.021_bib0008","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejim.2023.05.021_bib0009","doi-asserted-by":"crossref","first-page":"h158","DOI":"10.1136\/bmj.h158","article-title":"Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study","volume":"350","author":"Xu","year":"2015","journal-title":"Bmj"},{"issue":"16","key":"10.1016\/j.ejim.2023.05.021_bib0010","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ejim.2023.05.021_bib0011","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3949\/ccjm.86a.18024","article-title":"ACE inhibitors and ARBs: managing potassium and renal function","volume":"86","author":"Momoniat","year":"2019","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.05.021_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012818","article-title":"Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study","volume":"7","author":"Schmidt","year":"2017","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.ejim.2023.05.021_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005428","article-title":"Hyperkalemia After Initiating Renin-Angiotensin System Blockade: the Stockholm Creatinine Measurements (SCREAM) Project","volume":"6","author":"Bandak","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ejim.2023.05.021_bib0014","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12882-019-1633-2","article-title":"Estimating the risk of acute kidney injury associated with use of diuretics and renin angiotensin aldosterone system inhibitors: a population based cohort study using the clinical practice research datalink","volume":"20","author":"Scott","year":"2019","journal-title":"BMC Nephrol"},{"issue":"20","key":"10.1016\/j.ejim.2023.05.021_bib0015","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine Learning in Medicine","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.05.021_bib0016","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","article-title":"Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers","volume":"30","author":"Raebel","year":"2012","journal-title":"Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.ejim.2023.05.021_bib0017","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000013599","article-title":"Predictors of the Development of Hyperkalemia in Patients Using Angiotensin-Converting Enzyme Inhibitors","volume":"20","author":"Ahuja","year":"2000","journal-title":"Am. J. Nephrol."},{"issue":"6","key":"10.1016\/j.ejim.2023.05.021_bib0018","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jcpt.12720","article-title":"Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments","volume":"43","author":"Hirai","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.ejim.2023.05.021_bib0019","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"issue":"133","key":"10.1016\/j.ejim.2023.05.021_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.30699\/jambs.29.133.100","article-title":"Comparison of Four Data Mining Algorithms for Predicting Colorectal Cancer Risk","volume":"29","author":"Shanbehzadeh","year":"2021","journal-title":"Journal of Advances in Medical and Biomedical Research"},{"issue":"4","key":"10.1016\/j.ejim.2023.05.021_bib0021","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.kint.2019.11.037","article-title":"Electronic health records for the diagnosis of rare diseases","volume":"97","author":"Garcelon","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2023.05.021_bib0022","doi-asserted-by":"crossref","unstructured":"Magherini R., Mussi E., Volpe Y., et\u00a0al. Machine Learning for Renal Pathologies: an Updated Survey. Sensors (Basel). 2022;22(13). doi:10.3390\/s22134989.","DOI":"10.3390\/s22134989"},{"issue":"6","key":"10.1016\/j.ejim.2023.05.021_bib0023","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.kint.2020.02.028","article-title":"Machine learning, the kidney, and genotype\u2013phenotype analysis","volume":"97","author":"Sealfon","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ejim.2023.05.021_bib0024","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.xkme.2021.04.012","article-title":"Machine Learning Applications in Nephrology: a Bibliometric Analysis Comparing Kidney Studies to Other Medicine Subspecialities","volume":"3","author":"Verma","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.ejim.2023.05.021_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.946610","article-title":"Machine learning for the prediction of acute kidney injury in patients after cardiac surgery","volume":"9","author":"Xue","year":"2022","journal-title":"Front Surg"},{"issue":"5","key":"10.1016\/j.ejim.2023.05.021_bib0026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4239\/wjd.v7.i5.101","article-title":"Hyporeninemic hypoaldosteronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management","volume":"7","author":"Sousa","year":"2016","journal-title":"World J Diabetes"},{"issue":"1","key":"10.1016\/j.ejim.2023.05.021_bib0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5543\/tkda.2022.77567","article-title":"Remember Diabetes Mellitus When Assessing Renal Blood Flow in Hypertensive Patients: a Renal Frame Count Study","volume":"51","author":"\u00c7erik","year":"2023","journal-title":"Turk Kardiyol Dern Ars"},{"key":"10.1016\/j.ejim.2023.05.021_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154890","article-title":"Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies","volume":"124","author":"Ricciardi","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ejim.2023.05.021_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2020.01.046","article-title":"Uric acid and estimate of renal function. Let's stick together","volume":"310","author":"Borghi","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejim.2023.05.021_bib0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2022.06.061","article-title":"Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction","volume":"363","author":"Yano","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ejim.2023.05.021_bib0031","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","article-title":"Drug-Induced Hyperglycaemia and Diabetes","volume":"38","author":"Fathallah","year":"2015","journal-title":"Drug Saf"},{"issue":"34","key":"10.1016\/j.ejim.2023.05.021_bib0032","doi-asserted-by":"crossref","first-page":"E1351","DOI":"10.1503\/cmaj.202434","article-title":"Implementing machine learning in medicine","volume":"193","author":"Verma","year":"2021","journal-title":"Can Med Assoc J"},{"issue":"5","key":"10.1016\/j.ejim.2023.05.021_bib0033","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1213\/ANE.0000000000004575","article-title":"Realistically Integrating Machine Learning Into Clinical Practice: a Road Map of Opportunities, Challenges, and a Potential Future","volume":"130","author":"Hofer","year":"2020","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.ejim.2023.05.021_bib0034","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2196\/medinform.5359","article-title":"Challenges and Opportunities of Big Data in Health Care: a Systematic Review","volume":"4","author":"Kruse","year":"2016","journal-title":"JMIR Med Inform"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523001723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523001723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:38:57Z","timestamp":1760607537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523001723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"alternative-id":["S0953620523001723"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.05.021","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}